DCGO vs AMR vs HCC vs OPRX vs DOCS

For growth investors, DocGo Inc.

(DCGO) is the stronger pick with 522574% revenue growth year-over-year, versus -28. 0% for Alpha Metallurgical Resources, Inc. (AMR). Doximity, Inc. (DOCS) offers the better valuation at 23. 4x trailing P/E (16. 8x forward), making it the more compelling value choice. Analysts rate OptimizeRx Corporation (OPRX) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Doximity, Inc.

(DOCS) is the cheapest at 23. 4x versus Warrior Met Coal, Inc. at 79. 5x. On forward P/E, OptimizeRx Corporation is actually cheaper at 6. 8x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Alpha Metallurgical Resources, Inc.

(AMR) delivered a total return of +1167%, compared to -94. 3% for DocGo Inc. (DCGO). Over 10 years, the gap is even starker: AMR returned +1258% versus DCGO's -94. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Warrior Met Coal, Inc.

(HCC) is the lower-risk stock at 0. 57β versus OptimizeRx Corporation's 2. 14β — meaning OPRX is approximately 277% more volatile than HCC relative to the S&P 500. On balance sheet safety, Doximity, Inc. (DOCS) carries a lower debt/equity ratio of 1% versus 23% for DocGo Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), DocGo Inc.

(DCGO) is pulling ahead at 522574% versus -28. 0% for Alpha Metallurgical Resources, Inc. (AMR). On earnings-per-share growth, the picture is similar: OptimizeRx Corporation grew EPS 124. 5% year-over-year, compared to -1122. 2% for DocGo Inc.. Over a 3-year CAGR, DCGO leads at 89. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Doximity, Inc.

(DOCS) is the more profitable company, earning 39. 1% net margin versus -56. 6% for DocGo Inc. — meaning it keeps 39. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DOCS leads at 39. 9% versus -55. 3% for DCGO. At the gross margin level — before operating expenses — DOCS leads at 90. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, OptimizeRx Corporation (OPRX) trades at 6.

8x forward P/E versus 22. 9x for Alpha Metallurgical Resources, Inc. — 16. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OPRX: 164. 0% to $17. 00.

In this comparison, HCC (0.

4% yield) pays a dividend. DCGO, AMR, OPRX, DOCS do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Warrior Met Coal, Inc.

(HCC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 57), +1180% 10Y return). DocGo Inc. (DCGO) carries a higher beta of 2. 13 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HCC: +1180%, DCGO: -94. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (DCGO (Healthcare) and AMR (Energy) and HCC (Energy) and OPRX (Healthcare) and DOCS (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: DCGO is a small-cap high-growth stock; AMR is a small-cap quality compounder stock; HCC is a small-cap quality compounder stock; OPRX is a small-cap high-growth stock; DOCS is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.